Patient advocates

We have a limited number of discounted registrations of €60 for this conference for patient advocates affiliated with patient advocacy organisations.  

To apply for a discounted registration, you must: 

• Be employed by or volunteer for a registered non-profit patient advocacy organisation 
• Provide a headed letter from the organisation you represent, indicating how your attendance at the conference will further its charitable aims for the benefit of patients 
• Please contact us before the registration deadline to apply. 

Lay summary of the conference topic: 

T cells are a type of immune cell that can recognise and destroy cancer cells. New cancer treatments that harness T cells have transformed outcomes for some patients, but they can also cause serious side effects when T cells mistakenly attack healthy tissues. This conference will explore how T cells distinguish harmful targets, such as cancer, from the body’s normal cells. Researchers from immunology, computational biology, and clinical medicine will discuss new ways to better predict and control T cell behaviour. By improving the precision of T cell responses, this research could help develop safer and more effective cancer immunotherapies with fewer autoimmune side effects for patients.

Cancer patient organisations 

Connecting cancer researchers with patient advocacy organisations is crucial for fostering collaboration, empathy, and progress in cancer research. 

Explore our curated list.